245 related articles for article (PubMed ID: 16673296)
41. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
[TBL] [Abstract][Full Text] [Related]
42. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
43. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.
Rauschhuber C; Xu H; Salazar FH; Marion PL; Ehrhardt A
J Gene Med; 2008 Aug; 10(8):878-89. PubMed ID: 18470951
[TBL] [Abstract][Full Text] [Related]
44. Property of hepatitis B virus replication in Tupaia belangeri hepatocytes.
Sanada T; Tsukiyama-Kohara K; Yamamoto N; Ezzikouri S; Benjelloun S; Murakami S; Tanaka Y; Tateno C; Kohara M
Biochem Biophys Res Commun; 2016 Jan; 469(2):229-35. PubMed ID: 26654952
[TBL] [Abstract][Full Text] [Related]
45. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
46. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
[TBL] [Abstract][Full Text] [Related]
47. Correlation of hepatitis B core antigen and beta-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication.
Kim CW; Yoon SK; Jung ES; Jung CK; Jang JW; Kim MS; Lee SY; Bae SH; Choi JY; Choi SW; Han NI; Lee CD
J Gastroenterol Hepatol; 2007 Sep; 22(9):1534-42. PubMed ID: 17559383
[TBL] [Abstract][Full Text] [Related]
48. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
49. The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon.
Shlomai A; Shaul Y
Med Hypotheses; 2008; 71(1):53-7. PubMed ID: 18334285
[TBL] [Abstract][Full Text] [Related]
50. Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses.
De Mitri MS; Morsica G; Cassini R; Bagaglio S; Andreone P; Bianchi G; Loggi E; Bernardi M
Arch Virol; 2007 Feb; 152(2):395-404. PubMed ID: 16953307
[TBL] [Abstract][Full Text] [Related]
51. Mutations affecting the replication capacity of the hepatitis B virus.
Sheldon J; Rodès B; Zoulim F; Bartholomeusz A; Soriano V
J Viral Hepat; 2006 Jul; 13(7):427-34. PubMed ID: 16792535
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
53. Microfluidic platform for hepatitis B viral replication study.
Sodunke TR; Bouchard MJ; Noh HM
Biomed Microdevices; 2008 Jun; 10(3):393-402. PubMed ID: 18165913
[TBL] [Abstract][Full Text] [Related]
54. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
[TBL] [Abstract][Full Text] [Related]
55. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens.
Sugiyama M; Tanaka Y; Kato T; Orito E; Ito K; Acharya SK; Gish RG; Kramvis A; Shimada T; Izumi N; Kaito M; Miyakawa Y; Mizokami M
Hepatology; 2006 Oct; 44(4):915-24. PubMed ID: 17006908
[TBL] [Abstract][Full Text] [Related]
56. Evolution of multi-drug resistant hepatitis B virus during sequential therapy.
Yim HJ; Hussain M; Liu Y; Wong SN; Fung SK; Lok AS
Hepatology; 2006 Sep; 44(3):703-12. PubMed ID: 16941700
[TBL] [Abstract][Full Text] [Related]
57. Occult hepatitis B virus and hepatitis C virus infections.
Carreño V; Bartolomé J; Castillo I; Quiroga JA
Rev Med Virol; 2008; 18(3):139-57. PubMed ID: 18265423
[TBL] [Abstract][Full Text] [Related]
58. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
Ozasa A; Tanaka Y; Orito E; Sugiyama M; Kang JH; Hige S; Kuramitsu T; Suzuki K; Tanaka E; Okada S; Tokita H; Asahina Y; Inoue K; Kakumu S; Okanoue T; Murawaki Y; Hino K; Onji M; Yatsuhashi H; Sakugawa H; Miyakawa Y; Ueda R; Mizokami M
Hepatology; 2006 Aug; 44(2):326-34. PubMed ID: 16871568
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B virus induced hepatocellular carcinoma.
Chemin I; Zoulim F
Cancer Lett; 2009 Dec; 286(1):52-9. PubMed ID: 19147276
[TBL] [Abstract][Full Text] [Related]
60. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
